To further investigate whether other features of T cell exhaustion and impaired effector function in CD8+ T cells were also enhanced at CLL progression, we measured the co-expression of PD1 with other inhibitory receptors, namely CD244 and CD160 [33, 35]. Here, CD160 is linked to B-cell chronic lymphocytic leukemia.